Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis [Yahoo! Finance]
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis
Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference [Yahoo! Finance]
Biodesix, Inc. (BDSX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference [Yahoo! Finance]